Embodiments of the disclosure concern methods and compositions that include a substrate that comprises at least one fluorophore in sufficient amounts and delivery of the substrate to an individual in need of treatment. In specific embodiments, a sufficient amount of fluorescein is provided on a contact lens, for example, and delivered to an individual suffering from blepharospasm.
